| Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes | |
| Chen, Keguang; Zhang, Rui; Liu, Huanjun; Guo, Xi; Li, Pingli; Liu, Xuehong | |
| 刊名 | CLINICAL LABORATORY
 |
| 2016 | |
| 卷号 | 62期号:9页码:1773-1780 |
| 关键词 | CYP2C19 genetic polymorphisms clopidogrel clopidogrel resistance acute coronary syndrome |
| DOI | 10.7754/Clin.Lab.2016.160216 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4702762 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shandong Jiaotong Hosp, Dept Pharm, 12 Wuyingshanzhong Rd, Jinan 250031, Peoples R China. 2.Shandong Univ, Sch Med, Ji |
| 推荐引用方式 GB/T 7714 | Chen, Keguang,Zhang, Rui,Liu, Huanjun,et al. Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes[J]. CLINICAL LABORATORY,2016,62(9):1773-1780. |
| APA | Chen, Keguang,Zhang, Rui,Liu, Huanjun,Guo, Xi,Li, Pingli,&Liu, Xuehong.(2016).Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes.CLINICAL LABORATORY,62(9),1773-1780. |
| MLA | Chen, Keguang,et al."Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes".CLINICAL LABORATORY 62.9(2016):1773-1780. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论